← Back to all stories
Daily Vitamin C Shows Promise in Boosting Survival for Early-Stage Blood Cancer Patients
Photo: Anastasiia Chepinska / Unsplash
A new clinical trial indicates that a daily dose of vitamin C may significantly improve survival rates for individuals with precancerous blood disorders and early-stage blood cancers. Patients taking the accessible supplement also experienced fewer complications, offering a gentle and hopeful new pathway in leukemia care.
A new clinical trial indicates that a daily dose of vitamin C may significantly improve survival rates for individuals with precancerous blood disorders and early-stage blood cancers. Patients taking the accessible supplement also experienced fewer complications, offering a gentle and hopeful new pathway in leukemia care.